Trump administration reclassifies medical marijuana as less-dangerous drug under federal law
Updated
Updated · The Wall Street Journal · Apr 28
Trump administration reclassifies medical marijuana as less-dangerous drug under federal law
9 articles · Updated · The Wall Street Journal · Apr 28
The move shifts state-licensed medical marijuana from a category with LSD and heroin to one with anabolic steroids and Tylenol with codeine, following bipartisan support and rising daily cannabis use.
Despite legalization in 40 states and growing public support, only 27% of legal marijuana businesses are profitable, prompting states like California and New York to subsidize dispensaries with taxpayer funds.
While advocates cite social justice and racial equity, critics highlight increased marijuana potency, health risks for youth, and argue that drug legalization does little to address racial disparities in violent crime victimization.
As THC potency in cannabis skyrockets, are health warnings keeping pace with legalization?
Will rescheduling cannabis finally unlock the scientific research for new medicines?
With medical cannabis getting a tax break, will recreational businesses be left behind?
Marijuana laws are changing, but what about those with past federal convictions?
Medical marijuana is now Schedule III. Is full federal legalization of all cannabis next?